By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted April 1, 2019APYX MEDICAL CORPORATION PROVIDES UPDATE ON THE PREMARKET NOTIFICATION 510(K) SUBMISSION TO THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR USE IN DERMAL RESURFACING PROCEDURES; PROVIDES PRELIMINARY FIRST QUARTER 2019 REVENUE RESULTS AND REAFFIRMS 2019 REVENUE OUTLOOK READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted April 1, 2019APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON MAY 8, 2019 READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted February 7, 2019APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS ON MARCH 13, 2019 READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted January 14, 2019APYX MEDICAL CORPORATION ANNOUNCES THE PROMOTION OF TODD HORNSBY TO EXECUTIVE VICE PRESIDENT READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted January 7, 2019APYX MEDICAL CORPORATION REPORTS PRELIMINARY FULL YEAR AND FOURTH QUARTER 2018 REVENUE RESULTS READ MORE
